Cargando…

Cardiovascular-related deaths at the beginning of the COVID-19 outbreak: a prospective analysis based on the UK Biobank

OBJECTIVE: To assess the impact of the COVID-19 outbreak on cardiovascular disease (CVD) related mortality and hospitalisation. DESIGN: Community-based prospective cohort study. SETTING: The UK Biobank. PARTICIPANTS: 421 372 UK Biobank participants who were registered in England and alive as of 1 Ja...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Junren, Zhu, Jianwei, Yang, Huazhen, Hu, Yao, Sun, Yajing, Ying, Zhiye, Qu, Yuanyuan, Valdimarsdottir, Unnur, Fang, Fang, Song, Huan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8184350/
https://www.ncbi.nlm.nih.gov/pubmed/34088708
http://dx.doi.org/10.1136/bmjopen-2020-046931
_version_ 1783704575682805760
author Wang, Junren
Zhu, Jianwei
Yang, Huazhen
Hu, Yao
Sun, Yajing
Ying, Zhiye
Qu, Yuanyuan
Valdimarsdottir, Unnur
Fang, Fang
Song, Huan
author_facet Wang, Junren
Zhu, Jianwei
Yang, Huazhen
Hu, Yao
Sun, Yajing
Ying, Zhiye
Qu, Yuanyuan
Valdimarsdottir, Unnur
Fang, Fang
Song, Huan
author_sort Wang, Junren
collection PubMed
description OBJECTIVE: To assess the impact of the COVID-19 outbreak on cardiovascular disease (CVD) related mortality and hospitalisation. DESIGN: Community-based prospective cohort study. SETTING: The UK Biobank. PARTICIPANTS: 421 372 UK Biobank participants who were registered in England and alive as of 1 January 2020. PRIMARY AND SECONDARY OUTCOME MEASURES: The primary outcome of interest was CVD-related death, which was defined as death with CVD as a cause in the death register. We retrieved information on hospitalisations with CVD as the primary diagnosis from the UK Biobank hospital inpatient data. The study period was 1 January 2020 to June 30 2020, and we used the same calendar period of the three preceding years as the reference period. In order to control for seasonal variations and ageing of the study population, standardised mortality/incidence ratios (SMRs/SIRs) with 95% CIs were used to estimate the relative risk of CVD outcomes during the study period, compared with the reference period. RESULTS: We observed a distinct increase in CVD-related deaths in March and April 2020, compared with the corresponding months of the three preceding years. The observed number of CVD-related deaths (n=218) was almost double in April, compared with the expected number (n=120) (SMR=1.82, 95% CI 1.58 to 2.07). In addition, we observed a significant decline in CVD-related hospitalisations from March onwards, with the lowest SIR observed in April (0.45, 95% CI 0.41 to 0.49). CONCLUSIONS: There was a distinct increase in the number of CVD-related deaths in the UK Biobank population at the beginning of the COVID-19 outbreak. The shortage of medical resources for hospital care and stress reactions to the pandemic might have partially contributed to the excess CVD-related mortality, underscoring the need of sufficient healthcare resources and improved instructions to the public about seeking healthcare in a timely way.
format Online
Article
Text
id pubmed-8184350
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-81843502021-06-09 Cardiovascular-related deaths at the beginning of the COVID-19 outbreak: a prospective analysis based on the UK Biobank Wang, Junren Zhu, Jianwei Yang, Huazhen Hu, Yao Sun, Yajing Ying, Zhiye Qu, Yuanyuan Valdimarsdottir, Unnur Fang, Fang Song, Huan BMJ Open Cardiovascular Medicine OBJECTIVE: To assess the impact of the COVID-19 outbreak on cardiovascular disease (CVD) related mortality and hospitalisation. DESIGN: Community-based prospective cohort study. SETTING: The UK Biobank. PARTICIPANTS: 421 372 UK Biobank participants who were registered in England and alive as of 1 January 2020. PRIMARY AND SECONDARY OUTCOME MEASURES: The primary outcome of interest was CVD-related death, which was defined as death with CVD as a cause in the death register. We retrieved information on hospitalisations with CVD as the primary diagnosis from the UK Biobank hospital inpatient data. The study period was 1 January 2020 to June 30 2020, and we used the same calendar period of the three preceding years as the reference period. In order to control for seasonal variations and ageing of the study population, standardised mortality/incidence ratios (SMRs/SIRs) with 95% CIs were used to estimate the relative risk of CVD outcomes during the study period, compared with the reference period. RESULTS: We observed a distinct increase in CVD-related deaths in March and April 2020, compared with the corresponding months of the three preceding years. The observed number of CVD-related deaths (n=218) was almost double in April, compared with the expected number (n=120) (SMR=1.82, 95% CI 1.58 to 2.07). In addition, we observed a significant decline in CVD-related hospitalisations from March onwards, with the lowest SIR observed in April (0.45, 95% CI 0.41 to 0.49). CONCLUSIONS: There was a distinct increase in the number of CVD-related deaths in the UK Biobank population at the beginning of the COVID-19 outbreak. The shortage of medical resources for hospital care and stress reactions to the pandemic might have partially contributed to the excess CVD-related mortality, underscoring the need of sufficient healthcare resources and improved instructions to the public about seeking healthcare in a timely way. BMJ Publishing Group 2021-06-04 /pmc/articles/PMC8184350/ /pubmed/34088708 http://dx.doi.org/10.1136/bmjopen-2020-046931 Text en © Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) .
spellingShingle Cardiovascular Medicine
Wang, Junren
Zhu, Jianwei
Yang, Huazhen
Hu, Yao
Sun, Yajing
Ying, Zhiye
Qu, Yuanyuan
Valdimarsdottir, Unnur
Fang, Fang
Song, Huan
Cardiovascular-related deaths at the beginning of the COVID-19 outbreak: a prospective analysis based on the UK Biobank
title Cardiovascular-related deaths at the beginning of the COVID-19 outbreak: a prospective analysis based on the UK Biobank
title_full Cardiovascular-related deaths at the beginning of the COVID-19 outbreak: a prospective analysis based on the UK Biobank
title_fullStr Cardiovascular-related deaths at the beginning of the COVID-19 outbreak: a prospective analysis based on the UK Biobank
title_full_unstemmed Cardiovascular-related deaths at the beginning of the COVID-19 outbreak: a prospective analysis based on the UK Biobank
title_short Cardiovascular-related deaths at the beginning of the COVID-19 outbreak: a prospective analysis based on the UK Biobank
title_sort cardiovascular-related deaths at the beginning of the covid-19 outbreak: a prospective analysis based on the uk biobank
topic Cardiovascular Medicine
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8184350/
https://www.ncbi.nlm.nih.gov/pubmed/34088708
http://dx.doi.org/10.1136/bmjopen-2020-046931
work_keys_str_mv AT wangjunren cardiovascularrelateddeathsatthebeginningofthecovid19outbreakaprospectiveanalysisbasedontheukbiobank
AT zhujianwei cardiovascularrelateddeathsatthebeginningofthecovid19outbreakaprospectiveanalysisbasedontheukbiobank
AT yanghuazhen cardiovascularrelateddeathsatthebeginningofthecovid19outbreakaprospectiveanalysisbasedontheukbiobank
AT huyao cardiovascularrelateddeathsatthebeginningofthecovid19outbreakaprospectiveanalysisbasedontheukbiobank
AT sunyajing cardiovascularrelateddeathsatthebeginningofthecovid19outbreakaprospectiveanalysisbasedontheukbiobank
AT yingzhiye cardiovascularrelateddeathsatthebeginningofthecovid19outbreakaprospectiveanalysisbasedontheukbiobank
AT quyuanyuan cardiovascularrelateddeathsatthebeginningofthecovid19outbreakaprospectiveanalysisbasedontheukbiobank
AT valdimarsdottirunnur cardiovascularrelateddeathsatthebeginningofthecovid19outbreakaprospectiveanalysisbasedontheukbiobank
AT fangfang cardiovascularrelateddeathsatthebeginningofthecovid19outbreakaprospectiveanalysisbasedontheukbiobank
AT songhuan cardiovascularrelateddeathsatthebeginningofthecovid19outbreakaprospectiveanalysisbasedontheukbiobank